卡普拉齐祖马布:在与怀孕相关的免疫媒介性血栓性血栓细胞缩性紫外线中也是一个游戏改变者?
Paul Coppo1,2,3, Bérangère S Joly2,4,5,
1Service d'hématologie, AP-HP. 6 and Sorbonne - Université, Paris, France.
British journal of haematology
|June 9, 2023
概括
当标准疗法失败时,卡普拉奇祖马布在怀孕期间提供了免疫介导的血栓性血栓塞性紫外线 (iTTP) 的可行治疗方法. 这种方法为管理孕妇这种罕见的疾病提供了一个新的选择.
科学领域:
- 血液学 血液学 血液学
- 产科 产科 产科 产科 产科
- 免疫学 免疫学 免疫学
背景情况:
- 怀孕期间免疫介导的血栓性血栓性缺血性紫外线 (iTTP) 具有有限的治疗选择.
- 标准治疗包括治疗性血交换 (TPE) 和皮质类固醇,这可能并不总是能够快速控制疾病.
研究的目的:
- 评估卡普拉西祖马布的安全性和有效性,作为与怀孕相关的iTTP的额外治疗选择.
- 评估caplacizumab的作用,当传统的TPE和皮质激素治疗是不够的.
主要方法:
- 对Odetola等人撰写的案例报告的审查和评论. 关于卡普拉西祖马布在与怀孕相关的iTTP中的使用.
- 在怀孕期间患有严重iTTP的患者治疗结果的分析.
主要成果:
- 卡普拉西祖马布与TPE和皮质类固醇一起使用.
- 患者表现出积极反应,表明了潜在的疗效和安全性.
结论:
- 卡普拉西祖马布在怀孕期间的免疫介导的血栓性血栓塞性紫外线中是一个有希望和合理的治疗选择.
- 在标准TPE-皮质类固醇治疗不能快速控制疾病的情况下,它特别有价值.
相关概念视频
Transcytosis of IgG
2.8K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Mitral Valve Prolapse III: Nursing Management
18
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
18


